top of page

PLASBIO

Background

Non-clinical market size

The non-clinical market is expanding worldwide, driven by increasing demand for pharmaceutical and medical technology.

Non-clinical Market Status

In the post-COVID-19 era, global growth in the non-clinical market is driven by increased
demand for pharmaceutical and medical technology, along with the expansion of the AI drug development market.

Ripple effect

대지 1 사본 3_4x.png

Intellectual Property Rights

초안-31.png

PLASBIO
a company that creates
new values in technological
convergence

Patent applications and registrations in Korea

21

Overseas 
patent (US)

2

PCT

5

Trademark
rights

6

앵커 6

PLASBIO is a technology-oriented corporation that builds lab
animal study automation solution to move with the times of
the steadily growing biotech market.

We have grown to become a company that creates exceptional
values with competitive technologies of artificial intelligence
and 3D printing.

 

2018

2019

Conversion start-up: 
R&D, manufacturing

Established Ezmakers 
(3D printing education service business)

2020

Founded in 2020 (PLASBIO Inc.)

Microsoft-Korea Ministry of SMEs
and Startups (Majoong program)

Moved into Jeonju CAMTIC Advanced
Mechatronics Technology Institute

Chicago Matter Global member
in the United States

A mHUB Global Member in the United States

A member of TIPA

Korea Atomic Energy Research Institute KAERI 
Family corporate certification

Founded the research center

Moved into the Korea Atomic Energy Research 
Institute RFT commercialization

Research building

Certified as a company with excellent technologies
(Labware customized for lab animal studies)

2021

2022

2023

The 1st generation of IBK
Changgong Daejeon

KRIBB family company

TIPS R&D

INFORBENK, The Next Lab

KB Investment

Certification of venture enterprise

Dod-umgieob of Jeollabuk-do Province

Co-research: JOHNS HOPKINS  
INSTITUTE for NANOBIOTECHNOLOGY

Selected as a supplier of KAIST's 
biosynthesis research team

Ocean Bio signed an EVIO MOU

Btree MOU, NDA signed

First round of investment

Second round of investment

Expansion of Daejeon branch

Society of Neuroscience 2022 Announcement

73rd AALAS Excellent Research Poster Award

KBSI Convergence Innovation Team

BIO KOREA 2022 Smart Inject launch

First Penguin by Credit Guarantee Fund

BIO KOREA 2023 Smart Inject launch

AI voucher supplier selection

NVDIA inception program selection

​CES 2024 innovation award

bottom of page